Uncategorized
Weight Regain After Wegovy — Why It Happens & How to
Weight regain after Wegovy occurs in 60–70% of patients who stop treatment — here’s the hormonal mechanism behind it and the strategies that reduce
Wegovy Type 2 Diabetes — Does It Treat Blood Sugar or
Wegovy reduces A1C by up to 1.8% while delivering 15% weight loss at 68 weeks — but it’s FDA-approved for weight only, not diabetes treatment directly.
Wegovy Prediabetes — Does It Work Before You Have Diabetes?
Wegovy reduces prediabetes progression to type 2 diabetes by 73% in clinical trials. Here’s what that means for prevention, prescribing, and long-term use.
Wegovy Insulin Resistance — How GLP-1 Therapy Reverses It
Wegovy improves insulin resistance by activating GLP-1 receptors that restore beta-cell function and enhance glucose uptake — the mechanism works
Wegovy Obesity Treatment — Efficacy, Dosing & Real Results
Wegovy (semaglutide 2.4mg) delivers 14.9% mean weight loss in obesity treatment trials — here’s the dosing protocol, side effect timeline, and what most
Wegovy Cholesterol — Impact on Lipids & Heart Health
Wegovy reduces LDL cholesterol by 6–9% and triglycerides by 13–20% in clinical trials, independent of weight loss. Learn how the medication impacts
Wegovy Sleep Apnea — FDA Approval & Real Impact Results
Wegovy received FDA approval for obstructive sleep apnea in 2024, showing 25–35% reduction in AHI scores. How the GLP-1 mechanism works beyond weight loss
Wegovy NAFLD — GLP-1 Treatment for Fatty Liver Disease
Wegovy reduces liver fat by 59% in NAFLD patients via GLP-1 receptor modulation. Learn mechanisms, dose protocols, and realistic outcomes.
Wegovy Heart Disease — Cardiovascular Benefits Explained
Wegovy reduces major cardiovascular events by 20% in high-risk patients — here’s the mechanism, trial data, and what cardiologists actually recommend.
